Skip to main content
Clinical Trials/NCT02533882
NCT02533882
Completed
Not Applicable

Dose-Response Effects of Transformative Exercise in Improving Health and Function in Adults With Spinal Cord Injury and Multiple Sclerosis

University of Alabama at Birmingham1 site in 1 country180 target enrollmentDecember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
University of Alabama at Birmingham
Enrollment
180
Locations
1
Primary Endpoint
Grip Strength as measured by hand grip dynamometer
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study will examine the effectiveness of two types of group exercise classes on the health and functional status in inactive adults age 18-65 with neurological conditions including Multiple Sclerosis, stroke, and spinal cord injury (SCI). Participants will be randomly assigned to one of three groups; Movement to Music, Adapted Yoga, or a waitlist group who will complete a home-based exercise intervention of either Movement to Music or Adapted Yoga.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
August 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

James Rimmer

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with stroke
  • MS - mild to moderate disability (Patient Determined Disease Steps Score 0-6)
  • Able to use arms or arms/legs for exercise
  • Ambulatory or use manual wheelchair

Exclusion Criteria

  • Cognitive impairment (Mini-Mental State Exam score \< 24)
  • Recent weight change (+/- 25 pounds in 1 year)
  • Poorly controlled blood pressure
  • Cardiovascular disease event within the past six months
  • Severe pulmonary disease
  • Renal failure
  • Current tobacco user or quit within the last six months
  • Current use of medications for psychosis
  • Active pressure ulcers

Outcomes

Primary Outcomes

Grip Strength as measured by hand grip dynamometer

Time Frame: 12 weeks

Cardiorespiratory Fitness as measured by sub-maximal VO2

Time Frame: 12 weeks

Submax VO2 is assessed by the six minute walk test or the six minute push test. Participants wear a portable metabolic cart while walking or pushing

Fatigue as measured by PROMIS Fatigue Short Form 8a

Time Frame: 12 weeks

Pain as measured by PROMIS Pain Interference Short Form 8a

Time Frame: 12 weeks

Loneliness as measured by the Three-Item Loneliness Scale

Time Frame: 12 weeks

Strength as measured by Biodex System 3 Multijoint dynamometer

Time Frame: 12 weeks

Upper body strength is measured using a closed chain push/pull protocol. Lower body strength is measured using the knee flexion/extension protocol.

Balance as measured by Repeated Chair Stands

Time Frame: 12 weeks

The repeated chair stands test is performed by asking participants to stand up and sit down 5 times as fast as possible. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.

Balance as measured by the Timed Up and Go

Time Frame: 12 weeks

The Timed to Up and Go test is performed using a chair with arms. The participants stand up from the chair, walk to a mark measured three meters from the chair then return back to the seat. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.

Balance as measured by Biodex Limits of Stability

Time Frame: 12 weeks

The Limits of Stability test is performed on the Biodex SD balance machine using the limits of stability protocol created by Biodex.

Secondary Outcomes

  • Blood pressure(12 weeks)
  • Anthropometric measurements (weight)(12 weeks)
  • Depression as measured by PROMIS Emotional Distress-Depression Short Form 8a(12 weeks)
  • Health Biomarkers as measured by blood analysis (insulin)(12 weeks)
  • Health Biomarkers as measured by blood analysis (lipids)(12 weeks)
  • Health Biomarkers as measured by blood analysis (fasting glucose)(12 weeks)
  • Physical Function with Mobility Aid as measured by PROMIS Physical Function with Mobility Aid 455b(12 weeks)
  • Anxiety as measured by PROMIS Emotional Distress-Anxiety Short Form 8a(12 weeks)
  • PROMIS Pain Intensity Short Form(12 Weeks)
  • Circumference measurements to be reported as composite ratios (waist circumference, hip circumference, neck circumference)(12 weeks)
  • Ability to participate in social roles and activities as measured by PROMIS Ability to Participate in Social Roles and Activities Short Form 8a(12 weeks)
  • Nutrition Self-Efficacy as measured by the Nutrition Self-Efficacy Scale(12 weeks)
  • Physical Exercise Self-Efficacy as measured by the Physical Exercise Self Efficacy Scale(12 weeks)
  • Sleep Disturbance as measured by PROMIS Sleep Disturbance Short Form 8a(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials